Search Results

NU 6102 50mg 50mg  | Purity Not Available

Adooq Bioscience

NU6102 is selective for CDK1 and CDK2 compared to CDK4/D1 (IC50=1.6 ??M), DYRK1A (IC50=0.9 ??M), PDK1 (IC50=0.8 ??M) and ROCKII (IC50=0.6 ??M).

More Information Supplier Page

NU 6102 5mg 5mg  | Purity Not Available

Adooq Bioscience

NU6102 is selective for CDK1 and CDK2 compared to CDK4/D1 (IC50=1.6 ??M), DYRK1A (IC50=0.9 ??M), PDK1 (IC50=0.8 ??M) and ROCKII (IC50=0.6 ??M).

More Information Supplier Page

NU 6102 25mg 25mg  | Purity Not Available

Adooq Bioscience

NU6102 is selective for CDK1 and CDK2 compared to CDK4/D1 (IC50=1.6 ??M), DYRK1A (IC50=0.9 ??M), PDK1 (IC50=0.8 ??M) and ROCKII (IC50=0.6 ??M).

More Information Supplier Page

NU 6102 10mg 10mg  | Purity Not Available

Adooq Bioscience

NU6102 is selective for CDK1 and CDK2 compared to CDK4/D1 (IC50=1.6 ??M), DYRK1A (IC50=0.9 ??M), PDK1 (IC50=0.8 ??M) and ROCKII (IC50=0.6 ??M).

More Information Supplier Page

SU 5416 (Semaxinib) 50mg 50mg  | Purity Not Available

Adooq Bioscience

SU 5416 is an inhibitor of vascular endothelial growth factor receptor (VEGFR) that also inhibits other tyrosine kinases KIT, MET, FLT3 and RET.

More Information Supplier Page

SU 5416 (Semaxinib) 25mg 25mg  | Purity Not Available

Adooq Bioscience

SU 5416 is an inhibitor of vascular endothelial growth factor receptor (VEGFR) that also inhibits other tyrosine kinases KIT, MET, FLT3 and RET.

More Information Supplier Page

SU 5416 (Semaxinib) 100mg 100mg  | Purity Not Available

Adooq Bioscience

SU 5416 is an inhibitor of vascular endothelial growth factor receptor (VEGFR) that also inhibits other tyrosine kinases KIT, MET, FLT3 and RET.

More Information Supplier Page